LipoScience seeks to raise $86m in IPO to expand sales
This article was originally published in Clinica
LipoScience, a US developer of a test for managing patients' risk of cardiovascular disease, is aiming to raise $86.3m in an initial public offering on the Nasdaq.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.